Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -1.85 0.82 -2.74 12.45 9.54
Fund with Sales Charge (%) (POP) -2.74 0.82 -2.74 12.45 9.54
NASDAQ Biotechnology Index (%) -3.42 3.39 -1.17 13.82 11.02
S&P 500 Index (%) -6.98 5.10 6.72 10.53 6.69
Quarter EndAs of 03/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -1.85 0.82 -2.74 12.45 9.54
Fund with Sales Charge (%) (POP) -2.74 0.82 -2.74 12.45 9.54
NASDAQ Biotechnology Index (%) -3.42 3.39 -1.17 13.82 11.02
S&P 500 Index (%) -6.98 5.10 6.72 10.53 6.69

After-Tax Average Annual Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -3.94 -0.51 -4.19 11.02
Fund without Sales Charge (%) (NAV) After Shares Sold 0.80 0.61 -2.19 10.13
Fund with Sales Charge (%) (POP) Before Shares Sold -4.83 -0.51 -4.19 11.02
Fund with Sales Charge (%) (POP) After Shares Sold 0.27 0.61 -2.19 10.13
Quarter EndAs of 03/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -3.94 -0.51 -4.19 11.02
Fund without Sales Charge (%) (NAV) After Shares Sold 0.80 0.61 -2.19 10.13
Fund with Sales Charge (%) (POP) Before Shares Sold -4.83 -0.51 -4.19 11.02
Fund with Sales Charge (%) (POP) After Shares Sold 0.27 0.61 -2.19 10.13

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013
Fund without Sales Charge (%) (NAV) 33.83 -16.34 17.91 -17.75 4.71 32.95 67.44
Fund with Sales Charge (%) (POP) 32.83 -17.15 16.91 -18.54 3.75 31.95 66.44
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39

Cumulative Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -12.60 -12.60 -1.85 2.47 -12.97 223.40 679.00
Fund with Sales Charge (%) (POP) -13.47 -13.47 -2.74 2.47 -12.97 223.40 679.00
NASDAQ Biotechnology Index (%) -10.41 -10.41 -3.42 10.52 -5.70 265.12 954.58
S&P 500 Index (%) -19.60 -19.60 -6.98 16.11 38.47 172.10 330.05
Quarter EndAs of 03/31/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -12.60 -12.60 -1.85 2.47 -12.97 223.40 679.00
Fund with Sales Charge (%) (POP) -13.47 -13.47 -2.74 2.47 -12.97 223.40 679.00
NASDAQ Biotechnology Index (%) -10.41 -10.41 -3.42 10.52 -5.70 265.12 954.58
S&P 500 Index (%) -19.60 -19.60 -6.98 16.11 38.47 172.10 330.05

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 03/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 22.77 25.04
Standard Deviation (NASDAQ Biotechnology Index) 20.76 23.27 21.21
Beta 1.05 1.05
Sharpe Ratio -0.04 -0.15
Information Ratio -0.40 -0.26
Tracking Error 6.39 5.99

ADDITIONAL RISK STATISTICSAs of 03/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 1.00 0.95
Beta Bear 0.91 0.99
Bull Bear Capture Ratio 0.97 1.01
% of Positive Months 52.78 53.33
Gains/Losses 1.11 1.01
Maximum Drawdown
23.74 37.91

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 1.79%
Net Expense Ratio [further-information] 1.77%
Max Initial Sales Charge 0.00%
CDSC 1.00%

Volatility Measures [further-information] As of 03/31/2020 Updated Monthly, based on a 3-year period

Beta 1.05
Sharpe Ratio -0.04
Standard Deviation 22.77

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index